Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1
Jingping Zhong, … , Nancy Boudreau, Judith A. Varner
Jingping Zhong, … , Nancy Boudreau, Judith A. Varner
Published July 1, 2003
Citation Information: J Clin Invest. 2003;112(1):30-41. https://doi.org/10.1172/JCI17034.
View: Text | PDF
Article Cardiology

Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1

  • Text
  • PDF
Abstract

The ECM protein Del-1 is one of several novel ECM proteins that accumulate around angiogenic blood vessels in embryonic and tumor tissue and promote angiogenesis in the absence of exogenous growth factors. Del-1 expressed in mouse or rabbit ischemic hind-limb muscle by gene transfer rapidly promotes new blood vessel formation and restores muscle function. This angiogenic ECM protein initiates angiogenesis by binding to integrin αvβ5 on resting endothelium, thereby resulting in expression of the transcription factor Hox D3 and integrin αvβ3. Hox D3 converts resting endothelium to angiogenic endothelium by inducing expression of proangiogenic molecules such as integrin αvβ3. These findings provide evidence for an angiogenic switch that can be initiated in the absence of exogenous growth factors and indicate that the angiogenic matrix protein Del-1 may be a useful tool for the therapy of ischemic disease.

Authors

Jingping Zhong, Brian Eliceiri, Dwayne Stupack, Kalyani Penta, Gordon Sakamoto, Thomas Quertermous, Mike Coleman, Nancy Boudreau, Judith A. Varner

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
Del-1–αvβ5 interactions induce Hox D3 expression. (a) ECs were plated in...
Del-1–αvβ5 interactions induce Hox D3 expression. (a) ECs were plated in monolayers (–BM) or on tissue-culture plates coated with thin layers of basement membrane (+BM) prior to cell lysis and Western blot analysis for cyclin D1, p21cip, and integrins β3 and β5. (b) RT-PCR was performed for Hox D3, integrins β3 and β5, and GADPH (not shown). Relative levels of each PCR product were determined by densitometry in comparison with GADPH expression levels for each treatment. Asterisks indicate statistical significance relative to monolayer culture (–BM) (P < 0.02). (c) ECs were plated on endothelial monolayers in serum culture, BM + Del-1 (Del), or on BM + Del-1 with anti-αvβ5 function-blocking Ab’s (Del + P1F6), or control Ab’s (Del + cIgG). Integrin β5 and β5 protein expression levels were determined by Western blot analysis. Average expression levels for each integrin were determined in three experiments by densitometry. (d) RT-PCR was performed on RNA isolated from cells treated as in c for Hox D3, integrins β3 and β5, and GADPH. Relative levels of each PCR product were determined by densitometry in comparison with GADPH expression levels for each treatment. Asterisks indicate statistical significance relative to Del-1 stimulation (P < 0.02).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts